Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan

被引：0
|
作者：
Akira Yokomizo
Junji Yonese
Shin Egawa
Hiroshi Fukuhara
Hiroji Uemura
Kazuo Nishimura
Masayoshi Nagata
Atsushi Saito
Takumi Lee
Susumu Yamaguchi
Norio Nonomura
机构：
[1] Harasanshin Hospital,Department of Urology
[2] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Genitourinary Oncology
[3] Jikei University School of Medicine,Department of Urology
[4] Kyorin University School of Medicine,Department of Urology
[5] Yokohama City University Medical Center,Department of Urology and Renal Transplantation
[6] Osaka International Cancer Institute,Department of Urology
[7] Juntendo University Graduate School of Medicine,Department of Urology
[8] Astellas Pharma Inc.,Medical Affairs Japan
[9] Development,Department of Urology
[10] Astellas Pharma Inc.,undefined
[11] Osaka University Graduate School of Medicine,undefined
来源：
International Journal of Clinical Oncology | 2022年 / 27卷
关键词：
Efficacy; Enzalutamide; Japan; Nonmetastatic castration-resistant prostate cancer; Real world; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：418 / 426
页数：8
相关论文
共 50 条
  • [1] Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
    Yokomizo, Akira
    Yonese, Junji
    Egawa, Shin
    Fukuhara, Hiroshi
    Uemura, Hiroji
    Nishimura, Kazuo
    Nagata, Masayoshi
    Saito, Atsushi
    Lee, Takumi
    Yamaguchi, Susumu
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 418 - 426
  • [2] Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
    Akira Yokomizo
    Junji Yonese
    Shin Egawa
    Hiroshi Fukuhara
    Hiroji Uemura
    Kazuo Nishimura
    Masayoshi Nagata
    Atsushi Saito
    Takumi Lee
    Susumu Yamaguchi
    Norio Nonomura
    International Journal of Clinical Oncology, 2022, 27 : 633 - 634
  • [3] Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan (vol 27, pg 418, 2022)
    Yokomizo, Akira
    Yonese, Junji
    Egawa, Shin
    Fukuhara, Hiroshi
    Uemura, Hiroji
    Nishimura, Kazuo
    Nagata, Masayoshi
    Saito, Atsushi
    Lee, Takumi
    Yamaguchi, Susumu
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (03) : 633 - 634
  • [4] Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
    Hussain, Maha
    Fizazi, Karim
    Saad, Fred
    Rathenborg, Per
    Shore, Neal
    Ferreira, Ubirajara
    Ivashchenko, Petro
    Demirhan, Eren
    Modelska, Katharina
    Phung, De
    Krivoshik, Andrew
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2465 - 2474
  • [5] Re: Enzalutamide in Men with Nonmetastatic, Castration-resistant Prostate Cancer
    Mason, Malcolm
    EUROPEAN UROLOGY, 2018, 74 (06) : 845 - 845
  • [6] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [7] Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
    Sternberg, Cora N.
    Fizazi, Karim
    Saad, Fred
    Shore, Neal D.
    De Giorgi, Ugo
    Penson, David F.
    Ferreira, Ubirajara
    Efstathiou, Eleni
    Madziarska, Katarzyna
    Kolinsky, Michael P.
    Cubero, Daniel I. G.
    Noerby, Bettina
    Zohren, Fabian
    Lin, Xun
    Modelska, Katharina
    Sugg, Jennifer
    Steinberg, Joyce
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2197 - 2206
  • [8] Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 31 - 31
  • [9] Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
    Rhea, Logan P.
    Gupta, Brinda
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (02) : 107 - 108
  • [10] Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer
    Mori, Keiichiro
    Egawa, Shin
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2021, 79 (03) : 430 - 431
12345